Poseida Therapeutics Inc (PSTX)
2.76
-0.09
(-3.16%)
USD |
NASDAQ |
Jun 14, 16:00
2.77
+0.01
(+0.36%)
After-Hours: 20:00
Poseida Therapeutics Cash and Short Term Investments (Quarterly): 198.65M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 198.65M |
| December 31, 2023 | 212.20M |
| September 30, 2023 | 238.84M |
| June 30, 2023 | 214.61M |
| March 31, 2023 | 247.20M |
| December 31, 2022 | 282.49M |
| September 30, 2022 | 278.98M |
| June 30, 2022 | 142.56M |
| March 31, 2022 | 183.49M |
| Date | Value |
|---|---|
| December 31, 2021 | 206.32M |
| September 30, 2021 | 197.81M |
| June 30, 2021 | 237.26M |
| March 31, 2021 | 269.96M |
| December 31, 2020 | 309.15M |
| September 30, 2020 | 341.46M |
| June 30, 2020 | 167.13M |
| March 31, 2020 | 103.38M |
| December 31, 2019 | 125.32M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
103.38M
Minimum
Mar 2020
341.46M
Maximum
Sep 2020
219.82M
Average
213.40M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Biomea Fusion Inc | 144.92M |
| Cartesian Therapeutics Inc | 103.42M |
| NovaBay Pharmaceuticals Inc | 1.823M |
| Palatin Technologies Inc | 10.01M |
| iBio Inc | 5.302M |